Search

Displaying results 7881 - 7890 of 10000 in total
  1. Drug

    TAK-071

    go.drugbank.com/drugs/DB18954
    Investigational

    TAK-071 is under investigation in clinical trial NCT04334317 (A Study of TAK-071 in People With Parkinson Disease).

  2. Drug

    Rezpegaldesleukin

    go.drugbank.com/drugs/DB18992
    Investigational

    Rezpegaldesleukin is under investigation in clinical trial NCT04433585 (A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)).

  3. Drug

    Bovhyaluronidase azoximer

    go.drugbank.com/drugs/DB19020
    Investigational

    Bovhyaluronidase azoximer is under investigation in clinical trial NCT06458543 (Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age).

  4. Drug

    Minigastrin

    go.drugbank.com/drugs/DB19196
    Investigational

    Minigastrin is under investigation in clinical trial NCT06155994 (68ga-dota-mgs5 PET/CT in Patients With Advanced Neuroendocrine Tumours).

  5. Drug

    Exidavnemab

    go.drugbank.com/drugs/DB19452
    Investigational

    Exidavnemab is under investigation in clinical trial NCT06671938 (Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease).

  6. Drug

    GI heptapeptide

    go.drugbank.com/drugs/DB15070
    Investigational

    GI heptapeptide is under investigation in clinical trial NCT01391208 (Esophageal Protocol for Detection of Neoplasia in the Digestive Tract).

  7. Drug

    ELX-02

    go.drugbank.com/drugs/DB15080
    Investigational

    ELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult Subjects).

  8. Drug

    Fadraciclib

    go.drugbank.com/drugs/DB15425
    Investigational

    CYC-065 is under investigation in clinical trial NCT03739554 (CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL).

  9. Drug

    Tylosin

    go.drugbank.com/drugs/DB11475
    ExperimentalVet approved

    Tylosin is a bacteriostatic macrolide antibiotic and feed additive used in veterinary medicine. … It has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms. Tylosin is produced as a fermentation product of Streptomyces fradiae.

  10. Drug

    Zastumotide

    go.drugbank.com/drugs/DB14926
    Investigational

    It is under investigation in clinical trial NCT00257738 (0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck). … Zastumotide is a recombinant MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (MAGE-A3 ASCI) also known as astuprotimut-R.